Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

AIM/BXP stock hub

AIM/BXP has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

AIM/BXPis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

327.5M

London Stock Exchange AIM

Market data

Live price

Current market quote for this ticker.

Current price

AIM/BXP

In the news

Latest news · AIM/BXP

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8.9

P25 12.9P50 16.9P75 23.5

Trailing P/E7.7

P25 15.9P50 22.9P75 35.8

ROE12.5

P25 -54.2P50 2.1P75 13.7

ROIC12

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All AIM/BXP market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

BDT

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bangladesh
Country code	UK
Employees	1,122
Employees Change	112%
Employees Change Percent	11.09
Enterprise value	GBX 371.2M
Exchange	London Stock Exchange AIM
Financial currency	BDT
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	US0885792061
Last refreshed	2026-05-10
Market cap	GBX 327.5M
Price	GBX 42.5
Price currency	GBX
Rev Per Employee	275,500.77x
Sector	Healthcare
Sic	2834
Symbol	aim/BXP
Website	https://www.beximcopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	12.94%
EV Earnings	8.76x
EV/EBIT	7.04x
EV/EBITDA	5.85x
EV/FCF	13.59x
EV/Sales	1.34x
FCF yield	8.34%
Forward P/E	8.92x
P/B ratio	0.92x
P/E ratio	7.73x
P/S ratio	1.06x
PE Ratio10 Y	13.86x
PE Ratio3 Y	11.82x
PE Ratio5 Y	12.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.99%
EBITDA Margin	22.67%
FCF margin	8.84%
Gross margin	44.42%
Gross Profit	GBX 137.3M
Gross Profit Growth	14.22%
Gross Profit Growth Q	13.88%
Gross Profit Growth3 Y	10.76%
Gross Profit Growth5 Y	12.96%
Net Income	GBX 42.4M
Net Income Growth	29.23%
Net Income Growth Q	27.65%
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Net Income Growth3 Y	1.38%
Net Income Growth5 Y	14.34%
Pretax Margin	17.73%
Profit Margin	13.71%
Profit Per Employee	GBX 37,772
Profitable Years	19
ROA	7.62
Roa5y	7.06
ROCE	14.13
ROE	12.45
Roe5y	11.97
ROIC	12.04
Roic5y	10.37

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.45%
Cagr15y	7.08%
Cagr1y	8.98%
Cagr20y	5.97%
Cagr3y	-3.95%
Cagr5y	-12.75%
Div CAGR10	13.84%
Div CAGR3	-4.11%
Div CAGR5	15.88%
EPS Growth	29.23
EPS Growth Q	27.65
EPS Growth Quarters	7
EPS Growth Years	1
EPS Growth3 Y	1.38
EPS Growth5 Y	14.34
FCF Growth	-33.1%
FCF Growth3 Y	-0.72%
FCF Growth5 Y	33.52%
OCF Growth	-18.89%
OCF Growth Q	-41.02%
OCF Growth10 Y	10.43%
OCF Growth3 Y	-4.03%
OCF Growth5 Y	2.67%
Revenue Growth	11.26x
Revenue Growth Q	12.8x
Revenue Growth Quarters	34x
Revenue Growth Years	16x
Revenue Growth3 Y	13.06x
Revenue Growth5 Y	13.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	GBX 0.64
Assets	GBX 492.3M
Cash	GBX 19M
Current Assets	GBX 147.3M
Current Liabilities	GBX 69M
Debt	GBX 41.3M
Debt EBITDA	GBX 0.58
Debt Equity	GBX 0.12
Debt FCF	GBX 1.51
Equity	GBX 357.7M
Interest Coverage	8.48
Liabilities	GBX 134.6M
Long Term Assets	GBX 345M
Long Term Liabilities	GBX 65.6M
Net Cash	GBX -22.3M
Net Cash By Market Cap	GBX -6.8
Net Debt EBITDA	GBX 0.32
Net Debt Equity	GBX 0.06
Net Debt FCF	GBX 0.82
Tangible Book Value	GBX 295.4M
Tangible Book Value Per Share	GBX 0.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.13
Inventory Turnover	1.77
Net Working Capital	GBX 96.1M
Quick ratio	0.6
Working Capital	GBX 87.3M
Working Capital Turnover	GBX 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth Years	1%
Dividend per share	GBX 0
Dividend Years	11
Last Dividend	GBX 0.02
Payout Ratio	24.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	146.79%
1Y total return	8.97%
200-day SMA	41.04
3Y total return	-11.4%
50-day SMA	41.79
50-day SMA vs 200-day SMA	50over200
5Y total return	-49.42%
All Time High	131
All Time High Change	-67.56%
All Time High Date	2022-01-04
All Time Low	1.45
All Time Low Change	2,835.08%
All Time Low Date	2009-03-12
ATR	1.81
Ch YTD	8.97
High	42.5
High52	52.33
High52 Date	2025-08-26
High52ch	-18.79%
Low	42
Low52	31.55
Low52 Date	2025-05-02
Low52ch	34.71%
Ma50ch	1.7%
Price vs 200-day SMA	3.55%
RSI	52.09
RSI Monthly	51.01
RSI Weekly	51.43
Sharpe ratio	0.3x
Sortino ratio	0.64
Tr YTD	8.97
Tr15y	178.85%
Tr1m	11.84%
Tr3m	-6.59%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	GBX 58.7M
Operating Income Growth	20.1
Operating Income Growth Q	12.34
Operating Income Growth3 Y	9.21
Operating Income Growth5 Y	11.42
Operating margin	18.99

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-8,162,635.6
Shares Institutions	0.1%
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	GBX 27.3M
Average Volume	117,123x
Bv Per Share	0.74
CAPEX	GBX -16.9M
Ch10y	85.23
Ch15y	92.27
Ch1m	11.84
Ch1y	8.97
Ch20y	105.4
Ch3m	-6.59
Ch3y	-21.3
Ch5y	-57.71
Ch6m	16.44
Change	0%
Change From Open	1.19
Close	42.5
Days Gap	-1.18
Depreciation Amortization	10,196,727.7
Dollar Volume	45,900,000
Earnings Date	2026-01-27
EBIT	GBX 58.7M
EBITDA	GBX 70.1M
EPS	GBX 0.09
F Score	7
FCF	GBX 27.3M
FCF EV Yield	7.36x
Financing CF	-19,686,839
Fiscal Year End	June
Founded	1,976
Goodwill	4,033,008
Graham Number	75.786
Graham Upside	78.32
Income Tax	GBX 12.1M
Investing CF	-20,897,861
Is Primary Listing	0
Last Earnings Date	2026-01-27
Last Report Date	2024-12-31
Last Split Date	2020-11-23
Last Split Type	Forward
Lynch Fair Value	GBX 78.85
Lynch Upside	85.52
Ma150	42.18
Ma150ch	0.77%
Ma20	42.6
Ma20ch	-0.23%
Net CF	3,731,763
Open	42
P FCF Ratio	11.99
P OCF Ratio	7.4
Payment Date	2025-02-06
Position In Range	100
Ppne	261,232,234.4
Price Date	2025-12-31
Price EBITDA	GBX 4.67
Ptbv Ratio	1.11
Relative Volume	9.22x
Revenue	309,111,862x
Tax By Revenue	3.93x
Tax Rate	22.17%
Tr20y	219.1%
Tr6m	16.44%
Volume	1,080,000
Z Score	3.32

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does AIM/BXP pay a dividend?

Capital-return profile for this ticker.

Performance

AIM/BXP stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns AIM/BXP?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

AIM/BXP momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.1

Neutral momentum band

Price vs 200-day MA

+3.6%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.30

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About AIM/BXP

Hub-level FAQ points readers to the deeper analysis pages.

What is the current aim/BXP stock rating?

aim/BXP is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full aim/BXP analysis?

The full report lives at /stocks/aim/BXP/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for aim/BXP?

The latest report frames aim/BXP around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the aim/BXP page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.